Progavi® Oral Suspension: Each 10 ml Suspension contains Sodium Alginate BP 500 mg, Sodium Bicarbonate BP 213 mg & Calcium Carbonate BP 325 mg.
Progavi is the combination of two antacids (Calcium carbonate and Sodium bicarbonate) and an alginate (Sodium alginate).
The suspension work in two ways:
Due to presence of calcium and carbonates which act as an antacid, a time-interval of 2 hours should be considered between intake of this product and the administration of other medicinal products, especially H2-antihistamines, tetracyclines, digoxine, fluoroquinolones, iron salts, thyroid hormones, ketoconazole, neuroleptics, thyroxine, penicillamine, beta-blockers (atenolol, metoprolol), propranolol, glucocorticoid, chloroquine, diphenylphosphonates and estramine.
Overdose
Symptoms: Symptoms are likely to be minor in acute overdose; some abdominal distension may be noticed. Milk alkali syndrome has occurred in individuals taking large doses of calcium carbonate per day for prolonged periods.
Some common side effects are alkalosis, acid rebound, hypercalcaemia, milk-alkali syndrome & constipation which usually occurs following former the recommended dosages.
Based on clinical trial and previous experience Progavi® may be used during pregnancy, if clinically needed.
Breastfeeding: No effects of the active substance have been shown in breastfed newborns/ infants of treated mothers. This product can be used during breast-feeding if clinically needed.
Fertility: Clinical data do not suggest that this product has an effect on human fertility.
Do not store above 30°C. Keep in a dry place. Protect from light and keep out of the reach of children.
In-use shelf life
Use Progavi® Oral Suspension within 30 days once the container is opened. Keep the container closed after each opening.